
Bayer & ConcertAI Team Up, Tempus AI Secures $200M, and Yale & Google Launch Cell2Sentence-Scale - Life AI Weekly #15
April 30, 2025 -
Life AI Weekly
Hi there,
In this edition of Life AI Weekly, we're diving into the latest advancements in AI within the healthcare and life sciences sectors. Bayer has teamed up with ConcertAI to enhance precision oncology, aiming to improve cancer treatment outcomes. Meanwhile, Precision for Medicine and PathAI are collaborating to bring AI-driven services to clinical trials, potentially speeding up the development of new therapies. Johnson & Johnson is refocusing its AI strategy to concentrate on high-value use cases, ensuring that their AI initiatives deliver significant impact.
On the financial front, Tempus AI has secured $200 million to further develop its cancer model, while Araceli Biosciences raised $11.2 million for AI drug discovery. In healthcare technology, Axtria launched a new AI platform for life sciences, and SimonMed Imaging partnered with Lunit to enhance breast cancer detection using AI. These developments highlight the growing integration of AI in healthcare, promising to transform patient care and medical research.
Business, Investments & Partnerships
Harbinger Health has appointed Matt Turner as President and Hutan Ashrafian as Chief Medical Officer, while expanding its Board of Directors with Ajit Singh. Tempus AI has partnered with AstraZeneca and Pathos AI to develop a data-driven oncology model, securing $200 million for data licensing and model development. Araceli Biosciences has raised $11.2 million in Seed funding to enhance its AI-driven drug discovery efforts, focusing on high-content imaging and real-time analysis.
- Tempus AI Secures $200M Deal with AstraZeneca and Pathos AI
- Araceli Biosciences Raises $11.2M for AI Drug Discovery
- Youlify Secures $4.3 Million for AI-Driven Medical Billing
- Brellium Raises $16.7 Million for AI Healthcare Compliance
- Craif Secures $22 Million for AI Cancer Detection
- Gestalt Diagnostics Secures $7.5 Million for AI Pathology Platform
- Kardi AI Raises €1.1M for Cardiac Health Solution
- United Imaging Healthcare Reports 2024 and Q1 2025 Financial Results
- Persivia Secures $107 Million Investment from Aldrich Capital
- ProofPilot and Digital Medicine Society Collaborate on Clinical Trials
- Symphony Robotics Appoints New Chief Medical Officer
- Enlil, Inc. Launches AI Platform for MedTech Development
- Veeva Systems Launches AI Initiative for Life Sciences
- Harbinger Health Appoints New President and CMO
Drug Discovery
Bayer has signed a multiyear agreement with ConcertAI to advance its precision oncology efforts. Precision for Medicine and PathAI announced a strategic partnership to develop AI technologies for clinical trials. Johnson & Johnson is refocusing its AI strategy on high-value applications like drug discovery. O'Shaughnessy Ventures LLC awarded a $100,000 fellowship to AI researcher Miguel Solano. Unravel Biosciences seeks approval for clinical studies in Colombia for RVL-001.
- Bayer Partners with ConcertAI for Precision Oncology
- Precision for Medicine and PathAI Collaborate on AI Clinical Trial Services
- Johnson & Johnson Refocuses Generative AI Strategy
- O'Shaughnessy Ventures Awards Fellowship to AI Researcher
- Unravel Biosciences Submits Clinical Study Applications in Colombia
Research & Data
Yale University and Google Research have introduced Cell2Sentence-Scale, a new open-source language model. This tool is designed to translate complex cellular data into understandable language for researchers. Researchers from Google Research and Yale University have introduced C2S-Scale, a set of open-source models to interpret single-cell RNA sequencing data. HKUMed has developed the world's first AI model for diagnosing thyroid cancer, boasting over 90% accuracy and reducing consultation preparation time.
- Yale and Google Launch Cell2Sentence-Scale LLM
- Google and Yale Develop C2S-Scale for Single-Cell Analysis
- HKUMed Develops AI Model for Thyroid Cancer Diagnosis
Healthcare Tech
Axtria has introduced Axtria InsightsMAx.ai, an AI platform aimed at helping life sciences companies innovate by deploying, scaling, and monetizing AI solutions. SimonMed Imaging has partnered with Lunit to enhance AI technology for breast cancer detection. The Advanced Medical Technology Association and the Medical Device Manufacturers Association are requesting changes to the FDA's draft guidance on AI-enabled medical devices.
- Mayo Clinic Licenses MammoScreen AI for Radiology
- SimonMed Imaging Partners with Lunit for AI in Breast Cancer Detection
- Waystar Introduces AI to Cut Healthcare Waste
- Utah Enacts New AI Regulations
- House Rx Launches AI Pharmacy Platform
- AdvaMed Unveils AI Policy Roadmap for Congress
- ApolloMD and Cleo Health Collaborate on AI for Emergency Medicine
- Infinitus Systems Launches Voice AI Agents for Healthcare
- Simplex Quantum and University of Tokyo Unveil AI for Heart Monitoring
- OMRON Donates Blood Pressure Monitors with AI Technology
- Glytec Appoints New CTO to Boost AI in Medical Software
- Nabla Expands AI Partnership with Neighborhood Healthcare
- Abu Dhabi Health Leaders Discuss AI Governance in Healthcare
- Effingo Technology Appoints New Chief Legal Innovation Strategist
- ACR Warns of AI Discrimination Rule Enforcement in 2025
- Fractal Analytics Proposes AI Model to Improve Doctor-Patient Ratio
- LEM Surgical's Robotic System Gets FDA Clearance
- Anumana Expands AI Platform with Boston Scientific Investment
- Somatic Health and Kinetisense Start Clinical Study with Rothman Orthopaedics
- Clarius Mobile Health Launches FDA-Cleared Prostate AI Tool
- AI Study on Medical Cannabis for Cancer Treatment
- Alibaba's AI Tool for Pancreatic Cancer Gets FDA Breakthrough Status
- AI Tool SCAI Outperforms Physicians on USMLE
- La Fe Health Research Institute Constructs Supercomputer in Valencia
- Belong.Life and Equiva Partner for AI Mentors in Healthcare
- AI Platform Improves Cancer Detection in NHS Study
- RamSoft and Maverick Medical AI Launch AI Coding Solution
- Fangzhou Inc. Supports China's AI-Healthcare Initiative
- Health Catalyst Partners with Microsoft for AI in Healthcare
- Axtria Launches LUCCID for Clinical Data Management
- Radboudumc Develops AI Tool for Basal Cell Carcinoma Surgery
- Flagship Pioneering Launches Etiome for AI-Driven Healthcare
- Axtria Unveils AI Platform for Life Sciences
- Industry Groups Urge FDA to Revise AI Medical Device Guidance
- Former Nike VP Joins dBio as Board Advisor
- University of Utah Develops AI Toolkit for Chronic Disease Prediction
- Japan Develops AI That Passes Medical Exam
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.